Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals"Review Opinion of the Remuneration and Appraisal Committee of the Board of Directors on Matters Relating to the Grant of Restricted Shares to the Participants under the Company's 2026 Restricted Share Incentive Plan

· Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Review Opinion of the Remuneration and Appraisal Committee of the Board of Directors on Matters Relating to the Grant of Restricted Shares to the Participants under the Company's 2026 Restricted Share Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis